Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
Lee DE, Martinez-Escala ME, Serrano LM, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J. Lee DE, et al. Among authors: kaplan jb. JAMA Dermatol. 2018 Jul 1;154(7):828-831. doi: 10.1001/jamadermatol.2018.1264. JAMA Dermatol. 2018. PMID: 29874360 Free PMC article.
Targeted therapies for cutaneous T-cell lymphomas.
Kaplan JB, Guitart J, Giles FJ. Kaplan JB, et al. Expert Rev Hematol. 2014 Aug;7(4):481-93. doi: 10.1586/17474086.2014.942279. Expert Rev Hematol. 2014. PMID: 25025372 Review.
CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder.
Martinez-Escala ME, Kantor RW, Cices A, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J. Martinez-Escala ME, et al. Among authors: kaplan jb. J Am Acad Dermatol. 2017 Sep;77(3):489-496. doi: 10.1016/j.jaad.2017.05.015. Epub 2017 Jul 1. J Am Acad Dermatol. 2017. PMID: 28676328
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.
Martinez-Escala ME, Posligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, Zhou XA, Kaplan JB, Pro B, Choi J, Querfeld C, Rosen ST, Guitart J. Martinez-Escala ME, et al. Among authors: kaplan jb. J Am Acad Dermatol. 2018 Jun;78(6):1068-1076. doi: 10.1016/j.jaad.2017.12.068. Epub 2018 Jan 4. J Am Acad Dermatol. 2018. PMID: 29307643 Free PMC article.
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
Behdad A, Boddy CS, Fought AJ, Taxter T, Falkiewicz MK, Ayers E, Chen QC, Chen YH, Karmali R, Pro B, Winter JN, Landsburg DJ, Gordon LI, Kaplan JB. Behdad A, et al. Among authors: kaplan jb. Leuk Lymphoma. 2019 Dec;60(13):3266-3271. doi: 10.1080/10428194.2019.1622099. Epub 2019 Jun 21. Leuk Lymphoma. 2019. PMID: 31225766
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas.
Pearse WB, Petrich AM, Gordon LI, Karmali R, Winter JN, Ma S, Kaplan JB, Behdad A, Klein A, Jovanovic B, Helenowski I, Smith SM, Evens AM, Pro B. Pearse WB, et al. Among authors: kaplan jb. Leuk Lymphoma. 2021 Dec;62(14):3493-3500. doi: 10.1080/10428194.2021.1957867. Epub 2021 Aug 2. Leuk Lymphoma. 2021. PMID: 34338127 Clinical Trial.
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD. Landsburg DJ, et al. Among authors: kaplan jb. J Clin Oncol. 2017 Jul 10;35(20):2260-2267. doi: 10.1200/JCO.2017.72.2157. Epub 2017 May 5. J Clin Oncol. 2017. PMID: 28475457 Free PMC article.
168 results